Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
SynOx Therapeutics
Developer of treatment for diffuse tenosynovial giant cell tumors.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 31 Oct, 2024
"update inverses"
Golden AI
edited on 31 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
CTO
Broes Naeye
"update inverses"
Golden AI
edited on 31 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
CEO
Raymond Barlow
"Funding autocalculation"
Golden AI
edited on 31 Oct, 2024
Edits made to:
Infobox
(
+3
/
-3
properties)
Infobox
Latest Funding Round Date
April 22, 2024
Latest Funding Round Amount (USD)
75,000,000
Total Funding Amount (USD)
450,000,000
Latest Funding Round Date
October 30, 2024
Latest Funding Round Amount (USD)
92,000,000
Total Funding Amount (USD)
542,000,000
"Found on funding round"
Golden AI
edited on 31 Oct, 2024
Edits made to:
Infobox
(
+4
properties)
Infobox
Investors
HealthCap
Forbion Capital Partners
Gilde Healthcare
Bioqube Ventures
"update inverses"
Golden AI
edited on 31 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
SynOx Therapeutics Series B Round, October 2024
Jahir Khan
edited on 31 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
SynOx Therapeutics
Developer of treatment for diffuse tenosynovial giant cell tumors.
Infobox
Location
Dublin
Edits on 18 Sep, 2024
"update inverses"
Golden AI
edited on 18 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
SynOx Therapeutics April 2024 Series B Funding Round
"update inverses"
Golden AI
edited on 18 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
SynOx Therapeutics April 2024 Series B Funding Round
"update inverses"
Golden AI
edited on 18 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
SynOx Therapeutics April 2024 Series B Funding Round
"Funding autocalculation"
Golden AI
edited on 18 Sep, 2024
Edits made to:
Infobox
(
+1
/
-1
properties)
Infobox
Total Funding Amount (USD)
225,000,000
Total Funding Amount (USD)
450,000,000
Edits on 5 Sep, 2024
"update inverses"
Golden AI
edited on 5 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
SynOx Therapeutics April 2024 Series B Funding Round
"update inverses"
Golden AI
edited on 5 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
SynOx Therapeutics April 2024 Series B Funding Round
"update inverses"
Golden AI
edited on 5 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Funding Rounds
SynOx Therapeutics April 2024 Series B Funding Round
"Funding autocalculation"
Golden AI
edited on 5 Sep, 2024
Edits made to:
Infobox
(
+3
properties)
Infobox
Latest Funding Round Date
April 22, 2024
Latest Funding Type
Series B Round
Total Funding Amount (USD)
225,000,000
Edits on 15 Aug, 2024
"update entity type supersets"
Golden AI
edited on 15 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Is a
Organization
"Created via: prospector:3931:4133269"
Ivo Devereux
created this topic on 15 Aug, 2024
Edits made to:
Infobox
(
+11
properties)
Description
(
+66
characters)
SynOx Therapeutics
Developer of treatment for diffuse tenosynovial giant cell tumors.
Infobox
Is a
Company
Industry
Health technology
Biotechnology
Official Website
https://synoxtherapeutics.com
B2X
B2B
LinkedIn URL
https://www.linkedin.com/company/synox-therapeutics
Twitter URL
https://twitter.com/SynOx_Tx
Number of Employees (Ranges)
1 – 10
Founded Date
2020
Country
Republic of Ireland
Latest Funding Round Amount (USD)
75,000,000
Find more companies like SynOx Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE